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DIFFERENTIATION BETWEEN SARCOMATOUS AND
LEUKEMIC LYMPHOCYTES IN MICE*
A. KIRSCHBAUM,t W. U. GARDNER, R. NAHIGIAN, AND L. C. STRONG
The question as to whether human leukemia is to be classified as
a neoplasm or as an atypical hyperplastic response of the hemopoietic
tissues to an unknown agent has been the subject of much specula-
tion. The lymphosarcomata have been classified with the leukemias
by many investigators because of the obvious similarity certain cases
of leukemia bear to true neoplasms. The atypical cells of leukemia
usually show an extremely generalized distribution, whereas the
lymphosarcomatous cells exhibit local infiltrative growth with more
or less discrete foci of metastasis. Thus, leukemia has been con-
sidered by many to be a "systemic disease" (hyperplastic or neo-
plastic) with multicentric foci of origin, whereas the sarcomata
are said to be neoplasms of unicentric origin with or without
metastases."' 15
With the experimental study of leukemia and lymphosarcoma
in guinea-pigs and mice, much progress has been made in-acquiring
a more clear-cut understanding and classification." 12,' 13 14 On the
basis of transplantation experiments, leukemia in these animals has
definitely been demonstrated to be a neoplastic disease.
The nature of the growths (lymphosarcomatous or leukemic)
resulting from inoculation of different lines of neoplastic lympho-
cytes into uniform hosts is described in this paper. Variations in the
behavior of different neoplastic lymphocytes in the same environ-
ment might afford a basis for differentiation between lymphosarcoma
and leukemia.
Materials and methods
The experimental animals used were inbred mice of several strains-A,
F, C3H, CBA, C57. All of these strains have been maintained by brother-
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sister matings for many generations. In transplantation experiments young
mice were used to exclude spontaneous leukemia.
Three lines of malignant lymphoid disease were established in the A
strain, 2 in the CBA, 3 in the C3H, 1 in the C57, and 4 lymphoid and 3
myeloid in the F strain7 (Table 1). In addition, the Mal Fil 6 sarcoma of
TABLE I
LINES OF LEUKEMIA AND TYPE OF GROWTH FOLLOWING SUBCUTANEOUS AND
INTRAPERITONEAL INOCULATION
Cell Mouse No. ofposi-
line strain Transfers tifJe mice Type of disease
A* A 70 408 Small, flat, subcut. tumor plus systemic
disease
L** A 53 1300**** Large subcut. tumor plus systemic disease
G** A 49 275 Large infiltrative tumor, no systemic
disease
B* CBA 79 401 Small, flat, subcut. tumor plus systemic
disease
S CBA 6 18 Large local tumor, occasional metastases
C57** C57 9 19 Large local tumor, occasional systemic
disease
C** C3H 30 180 Large local tumor plus systemic disease
E** C3H 3 6 Small "
cc c c
D** C3H 3 10 Large " "
1I*** F 9 23 Small subcut. tumor plus systemic disease
2 F 29 66 Small " " " " "
3*** F 17 83 Large " " " " "
4*** F 9 37 Small " c " " CC
5 F 3 5 Small " " " c
6 F 12 70 Small " " " " "
7 F I 1 Small " " " cc cc
*These lines have reached a high degree of uniformity and are being maintained.
** Spontaneous cases occurred in mice receiving high doses of estrogen.
** Myelogenous leukemia. *** Reported by Lawrence, J. H., and Gardner, W. U.: Am. J. Cancer, 1938, 33,
112.
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Parsons* was studied.8 In making transplants the following technics were
used. Leukemic spleen, lymphosarcoma (locally growing transplanted tis-
sue), or Mal Fil 6 sarcoma was minced with scissors in physiological saline.
After the larger pieces of tissue had settled, a suspension containing large
numbers of intact cells was obtained. The concentration was determined
by using blood-cell counting methods. Intraperitoneal injections were made
through the abdominal wall, subcutaneous injections into the right axnlla,
and intravenous injections into a tail vein after the animal had been anes-
thetized by ether. In each case the suspension was drawn into a tuberculin
syringe through a 25-gauge needle. When different routes of inoculation
were used in the same experiment (Table 2) identical doses (1,300,000-13,-
000,000 cells) were given whatever the location of injection. An alternative
method for routine transfer was to place a few milligrams of fresh leukemic
or tumor tissue into a trocar and inoculate subcutaneously into the right axilla.
Mice were examined for tumors and for enlarged spleens and lymph
nodes by palpation at frequent intervals after experiments were started. Blood-
cell counts were made on blood obtained by snipping off a bit of tail; smears
were made by the conventional cover-slip method.
Liver, spleen, lymph nodes, kidneys, thoracic viscera, and tumors were
fixed in Zenker-formol, imbedded in paraffin, sectioned, and stained with
hematoxylin-eosin or eosin-orange G-toluidin-blue (Dominici). Touch prep-
arations of lymph nodes, liver, spleen, and bone-marrow were made. These
and the blood smears were stained by the May-Griunwald-Giemsa technic.5' 6
Only one of the 16 lines of malignant lymphoid or myeloid disease studied
never produced systemic lesions upon subcutaneous or intraperitoneal inocula-
tion of viable cells. This line has been designated line G. The original
lymphosarcoma arose in the mediastinum of a mouse injected with 14,250 i.u.
of hydroxy-estrin benzoate over a period of 206 days. In order to determine
whether this line would produce systemic disease when its cells were inocu-
lated intravenously, the following experiment, as summarized in Table 2, was
carried out. Cells of line G and line A (Table 1) were inoculated either
subcutaneously, intraperitoneally, or intravenously into separate groups of
mice. The behavior of leukemic and lymphosarcomatous cells could then be
studied in genetically uniform hosts. The Mal Fil 6 sarcoma of Parsons was
tested in the same way, since this tumor had shown a tendency to metastasize
to lymph nodes. Microscopically it is a sarcoma made up of undifferentiated
mesenchyme-like cells.
*This tumor was kindly supplied by Dr. Parsons of the Royal Cancer Hospital,
London. The authors are indebted to Dr. G. M. Smith, who secured the material.
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Observations
Sixteen transplantable lines of lymphoid or myeloid neoplastic
disease were established (Table 1). One (line G, Table 1) did not
produce metastatic growths upon subcutaneous or intraperitoneal
inoculation. Large infiltrative tumors (Figs. 1 and 3) appeared at
the inoculation sites. Line S in the CBA strain produced tumors
TABLE 2
RESULTS FOLLOWING INTRAVENOUS, INTRAPERITONEAL, AND SUBCUTANEOUS
INOCULATION OF SARCOMATOUS LYMPHOCYTES, LEUKEMIC
LYMPHOCYTES, AND MAL FIL 6 SARCOMA CELLS
No. Ave. days
Transfer No. Route No. with- longevity
genera- of of inoc- of out where takes
tion mice ulation Type of growth takes growth recorded
Line G Lymphosarcoma
28 & 29 21 Intrav. Local & metastasis (2) 4 17 35
systemic (2)
28 & 29 10 Subcut. Local 9 1 24
28 & 29 10 Intraper. Local 10 0 22
34 11 Intrav. Local 9 2 40
34 1 1 Subcut. Local 11 0 21
35 9 Intrav. Local (3),systemic (1) 4 5 53
35 6 Subcut. Local 6 0 28
36 9 Intrav.* None 0 9 months
36 9 Subcut.* Local 3 6 64
Line A Leukemia
36 12 Intrav. Systemic 12 0 17
36 20 Subcut. Systemic 20 0 18
36 20 Intraper. Systemic 20 0 26
53 5 Intrav. Systemic 5 0 17

















* 1,300,000 lymphocytes, the smallest dose of cells used.
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which metastasized infrequently. Systemic disease with diffuse infil-
tration of the lymphoid apparatus and other organs was not
observed. Line C57 sometimes produced only local tumors, but in
other instances systemic disease. Line D of strain C3H always pro-
duced a massive tumor, but metastatic tendencies were always
observed, and if the hosts lived long enough the typical infiltrations
of systemic leukemia appeared.7 The other lymphoid and myeloid
lines produced subcutaneous tumors of small or moderate size
(Fig. 2). White blood-cell counts were, in general, much higher
in the latter group than in the lines which showed a tendency toward
massive tumor growth. Leukemic blood pictures were not observed
in mice inoculated with cells of lines G, S, and C57. Only lines G,
S, C57, and D regularly produced massive tumors when the malig-
nant cells were introduced into the peritoneal cavity.
Of the 3 lines of myeloid leukemia studied, only one (line 3)
produced rather large subcutaneous growths. This tendency was
exhibited only after several transfer generations. The high white
blood-cell counts of 200,000 and above, which characterized the
early transfer generations, decreased to approximately 40,000 as
the local growths becamelarger in the later generations. Very small
local tumors and white blood-cell counts as high as 920,000 were
found in line 1. The cells of all lines studied, whether myeloid or
lymphoid, were capable of producing tumors in the subcutaneous
tissue.
The "pure" lymphosarcoma (line G) in the A strain (Figs. 1
and 3) usually retained its non-metastatic type of growth when
intravenous inoculations were made (Table 2). Tumors appeared
in 17 of the 50 mice inoculated by this route. In 12 of these, local
and markedly infiltrative growths resulted, exhibiting the same
characteristics as if transplanted under the skin. These tumors
appeared at various sites-mediastinum, lung, orbit, back of the
neck, and retroperitoneal areas. In 4 instances (transfer genera-
tions 28 and 29, Table 2) local tumors were produced at the site of
intravenous inoculation in the tail. Large pelvic tumors developed
in these animals. In addition, the inguinal and axillary lymph nodes
were infiltrated. In 2 cases accumulations of malignant cells were
present in the spleen and liver. Lymphocytic infiltrations were
found in the red pulp of the spleen, Malpighian corpuscles being
recognizable, however. In a fifth case (transfer generation 35,
Table 2) the malignant lymphocytes had infiltrated the bone-mar-
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row in addition to the spleen and liver. The thoracic and abdominal
cavities of this animal were filled with tumor tissue.
When cells of line G were introduced intravenously fewer ani-
mals developed tumors than when the same number of cells was
introduced either subcutaneously orintraperitoneally into other mice
of the A strain. Growths appeared in only 17 of the 50 animals
injected intravenously, whereas 39 of the 48 animals receiving simi-
lardoses ofcells bytheother routes ofinoculationdeveloped tumors.
Survival time after inoculation was longer in those animals develop-
ing tumors as a result of intravenous inoculation; 43 days as com-
pared with 24 days in controls receiving similar doses of cells either
intraperitoneally or subcutaneously (Table 2).
Routine subcutaneous and intraperitoneal transplantation experi-
ments with the Mal Fil 6 sarcoma of Parsons had demonstrated
occasional invasion of the mesenteric, axillary, mediastinal, lumbar,
and inguinal nodes. The lungs sometimes contained metastatic
nodules. Tumors developed in normal mice when portions of infil-
trated lymph nodes were inoculated. With intravenous inoculation
of cells a prolonged latent period preceded tumor development
(Table 2). In 3 of the 9 cases where growths appeared, they were
in the lungs.
When leukemic cells of line A (Table 2) were inoculated into
A-strain mice theend-result was the same, regardless of the route of
inoculation (Fig. 2). All lymph nodes were filled with leukemic
cells, the bloodwas leukemic, spleens were enlarged, periportal areas
in the liver were infiltrated, lungs were leukemic, bone-marrow was
replaced byleukemic lymphocytes, and perivascular and intertubular
accumulations of lymphocytes appeared in the kidneys. The latent
period was approximately the same following either subcutaneous,
intraperitoneal, or intravenous inoculation (Table 2).
In the 6th transfer generation of line A, before the line gave
uniform results, one mouse developed a large subcutaneous tumor
with apparently no distant metastases. An attempt was made to
establish a sarcomatous sub-line. Although hosts of the next trans-
fer generation developed rather large local tumors at the implanta-
tion site, systemic leukemia also appeared.
Discussion
The concept of the neoplastic nature of mouse leukemia is reaf-
firmed bythese experiments. In 12 transfer lines of frank leukemia
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subcutaneous tumors appeared when leukemic cells were inoculated
under the skin. These local tumors were composed of leukemic
cells, either lymphoid or myeloid. In all cases where the original
donor showed generalized leukemic lesions the cells of the lines
established from these cases produced leukemia as well as subcutane-
ous tumors following subcutaneous inoculation. Apparently, the
local tumors usually developed first and malignant lymphocytes
metastasized from the local tumor to lymph nodes, bone-marrow,
andthoracic andabdominal organs. In line G, which was established
from a spontaneous case of mediastinal lymphosarcoma without sys-
temic disease, cells failed to spread by way of the blood and lymph
stream from either subcutaneous or intraperitoneal tumors develop-
ing in hosts receiving inoculations of cells at these sites. Since fewer
takes resulted and the latent period was prolonged when the cells
were inoculated intravenously, it appears that the intravascular envi-
ronment was less favorable than the extravascular loci for the life
of these cells. In working with mice resistant to transplantable
leukemia, Furth, Seibold, and Rathbone3 found that, in general,
more takes were recorded if the intravenous rather than the sub-
cutaneous route of inoculation was used. In line G, however, fewer
takes were obtained with intravenous than subcutaneous inoculation.
It would seem that in most cases where intravenous inoculations
resulted in takes cells had probably left the circulation and had
formed lymphosarcomata at the point of escape. Although in a few
instances the distribution oflesions simulated that found in leukemia,
this does not necessarily mean that these cells are potentially leu-
kemic, since the Mal Fil 6 sarcoma, a non-lymphoid mesenchymal
tumor, behaved in a similar manner. Infiltrations of liver and spleen
by line G lymphocytes may have been by direct extension from large
abdominal tumors, since some tumors growing in the axilla invaded
the thoracic cavity by direct extension, the lungs then containing
peribronchial and perivascular accumulations of lymphocytes. Local
tumors composed of leukemic cells (Fig. 2) were similar micro-
scopically toline G lymphosarcomata (Fig. 3). Metastatic behavior
rather than histological characteristics differentiate the sarcomatous
from the leukemic lymphocytes.
Additional observations have shown that the incidence of lym-
phoid neoplastic disease is increased in mice receiving high doses
of estrogen.4 Many of the animals develop tumors in the medias-
tinum without metastases from this region. Upon transplantation
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into normal mice some of these tumors have produced systemic
leukemia. Although the spontaneous cases died with only local
infiltrative growths it might be assumed that the position of the
tumor was responsible for the death of the animal before metastatic
lesions appeared. In line G, however, the cells were really
"lymphosarcomatous" and not "leukemic." More mediastinal
tumors of spontaneous cases are being transplanted to determine
what proportion is capable of invading the blood stream.
The observations of Furth, Ferris, and Reznikoff' that the cells
which produce large tumors invade the blood with difficulty have
been confirmed. Apparently, gradations exist between lymphoid
neoplasms which do not invade the blood from an extravascular
site of growth (line G), those which invade the blood to only a
slight degree (lines S and C57), those which form massive local
tumors but always invade the blood (line C), and thosewhich invade
the blood and spread so readily by this route that the animals die
before local tumors have become very large (line A). These find-
ings are in general agreement with those of the above authors.' The
cells and not the hosts were apparently responsible for the different
types of growth noted in these observations. Furth, Ferris, and
Reznikoff' and Potter and MacDowell8 have shown, however, that
alterations in the hosts (irradiation with x-ray or partial immuniza-
tion) will modify the type of growth given by cell lines which have
become uniform for normal, susceptible hosts.
The excellent investigations of Potter, Victor, and Ward10 with
the C58 strain, whereby excision of single enlarged lymph nodes
suggested a delay in the appearance of spontaneous leukemia for
many months, presumably until another leukemic focus arose, indi-
cate the unicentric origin of even systemic leukemia. Excised nodes
in their experiments produced leukemia when inoculated into nor-
mal mice.* Leukemia may follow the inoculation of a single cell.2
Our observations indicate a wide range in the ability of different
malignant lymphocytes to invade the blood. It would seem from
the data now available that a single spontaneous locus of lymphoid
neoplasia can produce as an end-result either leukemia or lympho-
sarcoma, depending on the invasive character of the original malig-
nant lymphocytes. The factors responsible for these differences in
invasive character are still to be determined.
* Victor, J.: Personal communication.
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Sumnmary
1. Sixteen transfer lines of lymphoid and myeloid neoplastic
disease were established in 5 inbred strains of mice. When inocu-
lated under theskinthecells of 13 lines produced tumors which were
followed by metastatic lesions, those of 2 lines showed only a limited
tendency toward systemic spread after the formation of a subcutane-
ous tumor.
2. When inoculated eithersubcutaneously orintraperitoneally the
malignant lymphocytes of line G failed to produce systemic lesions
following the appearance of a local tumor. In cell doses ranging
from 1,300,000 to 13,000,000 cells 39 of 48 mice developed tumors.
Only 17 of 50 mice receiving similar doses intravenously developed
tumors. In 12 of the 17 instances where tumors developed follow-
ing intravenous inoculation these remained localized and infiltrative.
The dissemination ofmalignant lymphocytes was widespread enough
to designate the condition as leukemic in only 3 cases. The latent
period before sizeable tumors developed was prolonged when cells
were inoculated intravenously rather than by other routes (line G).
The route of inoculation did not alter the latent period or percent-
age of "takes" in a line of frank leukemia (line A) in the same
strain of mice.
Conclusions
Gradations exist between lines of lymphosarcoma and leukemia
in mice. Line G cells produce lymphosarcoma; other lines (S, C57,
and D) represent intermediate stages between lymphosarcoma and
leukemia. Cells of line G lymphosarcoma did not produce general-
ized (systemic) lesions when introduced into an extravascular locus;
takes were less frequent when malignant cells were introduced
directly into the blood stream. Cells of a transplantable leukemia
in the same strain produced systemic disease readily when inoculated
by any route. Since the hosts were uniform the cells of these 2 lines
determined the type of lymphoid disease, in one case "lymphosar-
coma," in the other "leukemia."
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literature review.)FIG. 1. Mouse bearing line G lymphosarcoma. A cellular suspension (36th trans-
fer) had been inoculated subcutaneously 20 days before photograph was taken. A
large tumor is present on the right side; liver, spleen, and lymph nodes are not
enlarged.
FIG. 2. Leukemic mouse inoculated subcutaneously with line A cells (65th trans-
fer) 9 days before photograph was taken. A small tumor is present on the right side
at the inoculation site. Spleen, liver, and lymph nodes (cervical, axillary, inguinal,
and mesenteric) are enlarged as a result of cellular infiltration.
FIG. 3. Section of lymphosarcoma shown in Fig. 1. Muscle fibers have been spread
apart and destroyed by infiltrating lymphocytes. Line G lymphocytes (sarcomatous)
did not metastasize from extravascular loci. Line A tumors composed of leukemic
lymphocytes were similar microscopically. Lymphocytes regularly metastasized, how-
ever, from such tumors. X 100.